Related Experiment Video
Updated: Dec 20, 2025

2-Methacryloyloxyethyl Phosphorylcholine Polymer Treatment of Complete Dentures to Inhibit Denture Plaque Deposition
Published on: December 26, 2016
Biodegradable phosphorylcholine copolymer for cardiovascular stent coating.
Jun Liu1, Jing Wang1, Yun-Fan Xue1
1MOE Key Laboratory of Macromolecule Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China. renkf@zju.edu.cn.
Researchers developed a biodegradable phosphorylcholine (PC) copolymer for stent coatings. This new material offers improved degradability while maintaining biocompatibility and drug-eluting capabilities for advanced medical devices.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Medical Device Engineering
Background:
- Phosphorylcholine (PC) based polymers are known for excellent biocompatibility in medical applications like drug-eluting stents.
- A key limitation for biodegradable stents is the poor degradability of current PC-based polymer coatings.
- Developing biodegradable alternatives is crucial for advancing stent technology.
Purpose of the Study:
- To synthesize a novel biodegradable phosphorylcholine copolymer for stent coatings.
- To investigate the copolymer's properties, including biocompatibility, degradability, and drug-eluting capacity.
- To evaluate the potential of this new copolymer for biodegradable stent applications.
Main Methods:
- Utilized one-step radical ring-opening polymerization (RROP) to synthesize the copolymer.
- Incorporated phosphorylcholine (PC), 2-methylene-1,3-dioxepane (MDO), and butyl methacrylate (BMA) monomers.
- Controlled copolymer composition by adjusting monomer ratios during polymerization.
- Fabricated stable coatings using ultrasonic spray deposition.
- Assessed blood compatibility, anti-adhesion, biodegradability, and drug (rapamycin) elution.
Main Results:
- Successfully synthesized a biodegradable PC copolymer with controllable monomer ratios (e.g., 34% MDO, 19% PC, 47% BMA).
- The resulting copolymer formed stable coatings via ultrasonic spray.
- Demonstrated excellent blood compatibility and anti-adhesion properties.
- Confirmed biodegradability and effective rapamycin elution capacity.
- In vivo studies indicated promising performance as a biodegradable stent coating.
Conclusions:
- A facile method was developed to create biodegradable PC-based polymers via RROP.
- The synthesized copolymer exhibits a desirable combination of biocompatibility, biodegradability, and drug delivery potential.
- This biodegradable PC copolymer shows significant promise for advanced biodegradable stent applications.
Related Concept Videos
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

